266 results on '"Zaidman, Craig M"'
Search Results
2. Intron mutations and early transcription termination in Duchenne and Becker muscular dystrophy.
3. Safety and efficacy of givinostat in boys with Duchenne muscular dystrophy (EPIDYS): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
4. Practical Considerations for Delandistrogene Moxeparvovec Gene Therapy in Patients With Duchenne Muscular Dystrophy
5. Onasemnogene abeparvovec for presymptomatic infants with two copies of SMN2 at risk for spinal muscular atrophy type 1: the Phase III SPR1NT trial
6. Onasemnogene abeparvovec for presymptomatic infants with three copies of SMN2 at risk for spinal muscular atrophy: the Phase III SPR1NT trial
7. Access to novel therapies for Duchenne muscular dystrophy—Insights from expert treating physicians
8. Management of Select Adverse Events Following Delandistrogene Moxeparvovec Gene Therapy for Patients With Duchenne Muscular Dystrophy
9. Safety and efficacy of givinostat in boys with Duchenne muscular dystrophy (EPIDYS): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
10. Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy in patients with two copies of SMN2 (STR1VE): an open-label, single-arm, multicentre, phase 3 trial
11. Evaluation for Late Nerve Transfer Surgery in Spinal Cord Injury: Predicting the Degree of Lower Motor Neuron Injury
12. Intramuscular blood flow in Duchenne and Becker Muscular Dystrophy: Quantitative power Doppler sonography relates to disease severity
13. Exploring the relationship between electrical impedance myography and quantitative ultrasound parameters in Duchenne muscular dystrophy
14. Indications for neuromuscular ultrasound: Expert opinion and review of the literature
15. The Use of Nerve Transfers to Restore Upper Extremity Function in Cervical Spinal Cord Injury
16. Delandistrogene Moxeparvovec Gene Therapy in Ambulatory Patients (Aged ≥4 to <8 Years) with Duchenne Muscular Dystrophy: 1‐Year Interim Results from Study SRP‐9001‐103 (ENDEAVOR)
17. Pamrevlumab, a Fully Human Monoclonal Antibody Targeting Connective Tissue Growth Factor, for Non-Ambulatory Patients with Duchenne Muscular Dystrophy
18. Intrathecal Onasemnogene Abeparvovec for Sitting, Nonambulatory Patients with Spinal Muscular Atrophy: Phase I Ascending-Dose Study (STRONG)
19. Skeletal muscle imaging in neuromuscular disease
20. CANOMAD and other chronic ataxic neuropathies with disialosyl antibodies (CANDA)
21. Evaluation of rAAVrh74 gene therapy vector seroprevalence by measurement of total binding antibodies in patients with Duchenne muscular dystrophy
22. sj-docx-1-tan-10.1177_17562864221149781 – Supplemental material for Evaluation of rAAVrh74 gene therapy vector seroprevalence by measurement of total binding antibodies in patients with Duchenne muscular dystrophy
23. Imaging of Skeletal Muscle in Neuromuscular Disease: A Clinical Perspective
24. Nerve ultrasound reliability of upper limbs: Effects of examiner training
25. Serial diaphragm ultrasound studies in neuralgic amyotrophy with bilateral phrenic neuropathies
26. Efficacy and Safety of Viltolarsen in Boys With Duchenne Muscular Dystrophy: Results From the Phase 2, Open-Label, 4-Year Extension Study.
27. Evaluation of Total Binding Antibodies Against rAAVrh74 in Patients with Duchenne Muscular Dystrophy (P14-13.005)
28. Motor and cognitive assessment of infants and young boys with Duchenne Muscular Dystrophy: results from the Muscular Dystrophy Association DMD Clinical Research Network
29. Quantitative Ultrasound of Skeletal Muscle: Reliable Measurements of Calibrated Muscle Backscatter from Different Ultrasound Systems
30. NERVE ULTRASOUND IDENTIFIES ABNORMALITIES IN THE POSTERIOR INTEROSSEOUS NERVE IN PATIENTS WITH PROXIMAL RADIAL NEUROPATHIES
31. Ultrasound of inherited vs. acquired demyelinating polyneuropathies
32. ELECTRICAL IMPEDANCE MYOGRAPHY IN DUCHENNE MUSCULAR DYSTROPHY AND HEALTHY CONTROLS: A MULTICENTER STUDY OF RELIABILITY AND VALIDITY
33. Quantitative ultrasound using backscatter analysis in Duchenne and Becker muscular dystrophy
34. MUSCLE ULTRASOUND QUANTIFIES DISEASE PROGRESSION OVER TIME IN INFANTS AND YOUNG BOYS WITH DUCHENNE MUSCULAR DYSTROPHY
35. OUTCOME RELIABILITY IN NON-AMBULATORY BOYS/MEN WITH DUCHENNE MUSCULAR DYSTROPHY
36. QUANTITATIVE MUSCLE ULTRASOUND IN DUCHENNE MUSCULAR DYSTROPHY: A COMPARISON OF TECHNIQUES
37. Long-Term Functional Efficacy and Safety of Viltolarsen in Patients with Duchenne Muscular Dystrophy.
38. Nerve size in chronic inflammatory demyelinating neuropathy varies with disease activity and therapy response over time: A retrospective ultrasound study
39. Quantitative muscle echointensity: A practical approach using ultrasound to evaluate children with suspected neuromuscular disorders
40. Six Month Results of Spinraza in Adults with Spinal Muscular Atrophy (SAS) Study (2446)
41. Minimal training is required to reliably perform quantitative ultrasound of muscle
42. The Spinal Muscular Atrophy Health Index: A novel outcome for measuring how a patient feels and functions
43. Laboratory monitoring of nusinersen safety
44. COENZYME Q10 DEFICIENCY IN CHILDREN: FREQUENT TYPE 2C MUSCLE FIBERS WITH NORMAL MORPHOLOGY
45. Imaging of Skeletal Muscle in Neuromuscular Disease: A Clinical Perspective
46. Medical management of muscle weakness in Duchenne muscular dystrophy
47. Pulse oral corticosteroids in pediatric chronic inflammatory demyelinating polyneuropathy
48. NEWBORN BRACHIAL PLEXUS PALSY: EVALUATION OF SEVERITY USING QUANTITATIVE ULTRASOUND OF MUSCLE
49. Onasemnogene abeparvovec for presymptomatic infants with three copies of SMN2at risk for spinal muscular atrophy: the Phase III SPR1NT trial
50. Onasemnogene abeparvovec for presymptomatic infants with two copies of SMN2at risk for spinal muscular atrophy type 1: the Phase III SPR1NT trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.